P&G Procter & Gamble Bets Big on Wellness with $3.8 Billion Thorne Acquisition

Procter & Gamble has agreed to acquire high-growth supplement brand Thorne in a $3.8 billion deal, ramping up its expansion into the rapidly expanding health, beauty, and self-care industry.

P&G Chief Executive Officer Shailesh Jejurikar confirmed the transaction during an interview on CNBC, highlighting Thorne’s position as a premium wellness brand that addresses shifting consumer demographics and surging demand for science-backed nutritional products.

“We are really excited about that because it really plays in a very high-growth segment of supplements and wellness, something that is really a big trend right now,” Jejurikar stated. He added that the $3.8 billion purchase price aligns with prevailing industry benchmarks for high-growth consumer health assets.

Deal Overview: Key Transaction Highlights

Expanding P&G’s Personal Care and Wellness Footprint

The acquisition represents P&G’s largest move in the personal health and nutritional supplement space in recent years. Known primarily for household staples such as Tide, Pampers, and Gillette, the Cincinnati-based consumer goods giant has systematically expanded its health and personal care divisions to capture higher-margin, discretionary consumer spending.

Thorne will join P&G’s existing lineup of digestive and dietary health products, which includes well-known brands such as:

• Metamucil (fiber supplements)

• Align (probiotics)

• New Chapter (whole-food vitamins and herbs)

While P&G recently reported slower overall sales growth across its legacy household categories, its beauty, personal care, and specialized health divisions have delivered persistent strength. Modern consumers—particularly younger demographics—continue to prioritize preventive healthcare, longevity products, and personalized nutrition despite broader inflationary pressures.

Strategic Rationale: Why Thorne Command a $3.8 Billion Price Tag

Founded in 1984, Thorne built its reputation as a clinical-grade, practitioner-recommended brand specializing in testing kits and personalized dietary supplements, ranging from high-absorption magnesium to omega-3 formulations and electrolyte blends.

Several key factors drove the strong competitive interest and ultimate $3.8 billion valuation for the Thorne brand:

• Young, Highly Engaged Customer Base: Shoppers under 40 make up the majority of Thorne’s customer base. This demographic displays high brand loyalty, frequently subscribes to recurring direct-to-consumer order models, and seeks out science-backed wellness routines.

• Rapid Top-Line Revenue Growth: Thorne generated approximately $500 million in revenue in 2025 and is on track to surpass $650 million in 2026. This trajectory makes it one of the fastest-growing wellness properties in the global consumer health market.

• Differentiated Clinical Position: Unlike generic mass-market vitamin brands, Thorne leverages clinical testing, rigorous manufacturing standards, and partnerships with elite athletic organizations to position itself as a premium, science-first product line.

• Synergies with P&G Supply Chain & Distribution: By integrating Thorne into P&G’s vast global retail and distribution footprint, P&G can rapidly scale Thorne’s reach across international markets and pharmacy channels.

The Journey of Thorne: From Nasdaq to Private Equity and P&G

Thorne’s path to a $3.8 billion corporate acquisition highlights the rapid consolidation and value creation currently taking place across the wellness sector:

• 2021 Public Listing: Thorne went public on the Nasdaq stock exchange in late 2021 at a valuation of approximately $525 million.

• 2023 Take-Private Buyout: Consumer-focused private equity firm L Catterton—backed by French luxury conglomerate LVMH—acquired Thorne in a take-private transaction valued at $680 million.

• 2026 Bidding War: After putting Thorne up for sale, L Catterton generated intense bidding from major global consumer health players, including UK-based Haleon and international rival Unilever.

• P&G’s Winning Bid: P&G ultimately outbid competing suitors, securing the asset for $3.8 billion—yielding a substantial return for L Catterton in under three years.

Broader Consumer Health Trends and Market Outlook

The acquisition comes as global consumer conglomerates increasingly pivot toward high-growth, high-margin health, self-care, and longevity categories. Demand for dietary supplements, functional hydration, and preventive health solutions has accelerated as wellness shifts from an occasional purchase to a daily lifestyle habit.

Industry analysts note that while macro economic shifts have caused consumers to tighten budgets on traditional fast-moving consumer goods, spending on personal wellness and health maintenance remains resilient.

P&G’s acquisition of Thorne positions the consumer giant to capture additional market share in premium nutrition, ensuring its portfolio remains aligned with long-term demographic shifts favoring health, wellness, and preventive care.